Carl Icahn (Heidi Gutman/CNBC/NBCU Photo Bank/NBCUniversal via Getty Images)
March 13, 2023 07:19 AM EDTUpdated 02:16 PM
People
Startups

Up­dat­ed: Carl Ic­ahn pro­pos­es three new Il­lu­mi­na board mem­bers in proxy fight

Kyle LaHucik

Senior Reporter

A proxy fight is brew­ing at Il­lu­mi­na as ac­tivist in­vestor Carl Ic­ahn ar­gues that the DNA se­quenc­ing gi­ant is cost­ing share­hold­ers bil­lions by fol­low­ing through …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times